Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes

Diabetes

Volumn 55, Issue 1, 2006, Pages 102-109

  Segal, Mark S ^a   Shah, Ronak ^a   Afzal, Aqeela ^a   Perrault, Cecile M ^b   Chang, Kyunghee ^a   Schuler, Anna ^a   Beem, Elaine ^a   Shaw, Lynn C ^a   Calzi, Sergio Li ^a   Harrison, Jeffrey K ^a   Tran Son Tay, Roger ^b   Grant, Maria B ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b University of Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; DIETHYLENETRIAMINE; DIPEPTIDYL PEPTIDASE IV; NITRIC OXIDE; NITRIC OXIDE DONOR; PHOSPHOPROTEIN; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

ARTICLE; CELL ISOLATION; CELL MIGRATION; CELL STRUCTURE; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSKELETON; DIABETES MELLITUS; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INACTIVATION; HUMAN; HUMAN CELL; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; STEM CELL;

EID: 33644756701     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/diabetes.55.01.06.db05-0803     Document Type: Article

References (45)

1. Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T, Honjo T: Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 261:600-603, 1993
2. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T: Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:635-638, 1996
3. Kawabata K, Ujikawa M, Egawa T, Kawamoto H, Tachibana K, Iizasa H, Katsura Y, Kishimoto T, Nagasawa T: A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution. Proc Natl Acad Sci U S A 96:5663-5667, 1999
4. Onai N, Zhang Y, Yoneyama H, Kitamura T, Ishikawa S, Matsushima K: Impairment of lymphopoiesis and myelopoiesis in mice reconstituted with bone marrow-hematopoietic progenitor cells expressing SDF-1-intrakine. Blood 96:2074-2080, 2000
5. Ratajczak MZ, Kucia M, Reca R, Majka M, Janowska-Wieczorek A, Ratajczak: Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells 'hide out' in the bone marrow. Leukemia 18:29-40, 2004
6. Christopherson KW 2nd, Hangoc G, Mantel CR, Broxmeyer HE: Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305:1000-1003, 2004
7. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S: Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95:952-958, 2000
8. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967, 1997
9. Brooks HL Jr, Caballero S Jr, Newell CK, Steinmetz RL, Watson D, Segal MS, Harrison JK, Scott EW, Grant MB: Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone. Arch Ophthalmol 122:1801-1807, 2004
10. Grant MB, May WS, Caballero S, Brown GA, Guthrie SM, Mames RN, Byrne BJ, Vaught T, Spoerri PE, Peck AB, Scott EW: Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 8:607-612, 2002
11. Grant MB, Ellis EA, Caballero S, Mames RN: Plasminogen activator inhibitor-1 overexpression in nonproliferative diabetic retinopathy. Exp Eye Res 63:233-244, 1996
12. Grant MB, Tarnuzzer RW, Caballero S, Ozeck MJ, Davis MI, Spoerri PE, Feoktistov I, Biaggioni I, Shryock JC, Belardinelli L: Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Circ Res 85:699-706, 1999
13. Christopherson KW 2nd, Hangoc G, Broxmeyer HE: Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells. J Immunol 169:7000-7008, 2002
14. Perrault CM, Bray EJ, Didier N, Ozaki CK, Tran-Son-Tay R: Altered rheology of lymphocytes in the diabetic mouse. Diabetologia 47:1722-1726, 2004
15. Ohtsuki T, Hosono O, Kobayashi H, Munakata Y, Souta A, Shioda T, Morimoto C: Negative regulation of the anti-human immunodeficiency virus and chemotactic activity of human stromal cell-derived factor 1alpha by CD26/dipeptidyl peptidase IV. FEBS Lett 431:236-240, 1998
16. Proost P, Struyf S, Schols D, Durinx C, Wuyts A, Lenaerts JP, De Clercq E, De Meester I, Van Damme: Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha. FEBS Lett 432:73-76, 1998
17. Tran-Son-Tay R, Needham D, Yeung A, Hochmuth RM: Time-dependent recovery of passive neutrophils after large deformation. Biophys J 60:856-866, 1991
18. Hochmuth RM, Ting-Beall HP, Beaty BB, Needham D, Tran-Son-Tay R: Viscosity of passive human neutrophils undergoing small deformations. Biophys J 64:1596-1601, 1993
19. Nash GB, Johnson CS, Meiselman HJ: Mechanical properties of oxygenated red blood cells in sickle cell (HbSS) disease. Blood 63:73-82, 1984
20. Athanassiou G, Matsouka P, Kaleridis V, Missirlis Y: Deformability and filterability of white blood cell subpopulations: evaluation of these parameters in the cell line HL-60 and in type II diabetes mellitus. Clin Hemorheol Microcirc 22:35-43, 2000
21. Linderkamp O, Ruef P, Zilow EP, Hoffmann GF: Impaired deformability of erythrocytes and neutrophils in children with newly diagnosed insulin-dependent diabetes mellitus. Diabetologia 42:865-869, 1999
22. Yao W, Gu L, Sun D, Ka W, Wen Z, Chien S: Wild type p53 gene causes reorganization of cytoskeleton and, therefore, the impaired deformability and difficult migration of murine erythroleukemia cells. Cell Motil Cytoskeleton 56:1-12, 2003
23. Glover S, Delaney M, Dematte C, Kornberg L, Frasco M, Tran-Son-Tay R, Benya RV: Phosphorylation of focal adhesion kinase tyrosine 397 critically mediates gastrin-releasing peptide's morphogenic properties. J Cell Physiol 199:77-88, 2004
24. Chen H, Yunpeng W, Shaoxi C, Mian LA: Research on rheological properties of erythrocyte of lung cancer patients. Clin Hemorheol 16:135-141, 1996
25. Khan MM, Puniyani RR, Huilgog NG, Hussain A, Ranade GG: Hemorheological profile in cancer patients. Clin Hemorheol 15:37-44, 1995
26. Guthrie SM, Curtis LM, Mames RN, Simon GG, Grant MB, Scott EW: The nitric oxide pathway modulates hemangioblast activity of adult hematopoietic stem cells. Blood 105:1916-1922, 2005
27. Dickinson RB, Purich DL: Clamped-filament elongation model for actinbased motors. Biophys J 82:605-617, 2002
28. Krause M, Dent EW, Bear JE, Loureiro JJ, Gertler FB: Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu Rev Cell Dev Biol 19:541-564, 2003
29. Andre M, Latado H, Felley-Bosco E: Inducible nitric oxide synthase-dependent stimulation of PKGI and phosphorylation of VASP in human embryonic kidney cells. Biochem Pharmacol 69:595-602, 2005
30. Wang H-G, Lu F-M, Jin I, Udo H, Kandel ER, de Vente J, Walter U, Lohmann SM, Hawkins RD, Antonova I: Presynaptic and postsynaptic roles of NO, cGK, and RhoA in long-lasting potentiation and aggregation of synaptic proteins. Neuron 45:389-403, 2005
31. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, Ledda FJ: Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94:2036-2044, 1994
32. Brownlee MD: Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46:223-234, 1995
33. King GL, Brownlee M: The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am 25:255-270, 1996
34. Lo YYC, Cruz TF: Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J Biol Chem 270:11727-11730, 1995
35. Lo YYC, Wong JMS, Cruz TF: Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J Biol Chem 271:15703-15707, 1996
36. Nakamura H, Nakamura K, Yodoi J: Redox regulation of cellular activation. Annu Rev Immunol 15:351-369, 1997
37. Nguyen A, Chen P, Cai H: Role of CaMKII in hydrogen peroxide activation of ERK1/2, p38 MAPK, HSP27 and actin reorganization in endothelial cells. FEBS Lett 572:307-313, 2004
38. Ross R, Glomset J, Harker L: Response to injury and atherogenesis. Am J Pathol 86:675-684, 1977
39. Ross R: Atherosclerosis: an inflammatory disease. N Engl J Med 340:115-126, 1999
40. Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA: Atherosclerosis: an inflammatory disease. J Clin Invest 106:571-578, 2000
41. Sivan-Loukianova E, Awad OA, Stepanovic V, Bickenbach J, Schatteman GC: CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds. J Vas Res 40:368-377, 2003
42. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, Martin H, Zeiher AM, Dimmeler S: Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109:1615-1622, 2004
43. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89:E1-E7, 2001
44. Deacon CF, Ahren B, Holst J: Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of type 2 diabetes? Expert Opin Investig Drugs 13:1091-1102, 2004
45. Holst JJ, Deacon CF: Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus. Curr Opin Pharmacol 4:589-596, 2004